The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksF.b.d.hldgs Regulatory News (FBH)

Share Price Information for F.b.d.hldgs (FBH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.75
Bid: 13.20
Ask: 14.30
Change: 0.00 (0.00%)
Spread: 1.10 (8.333%)
Open: 13.75
High: 13.75
Low: 13.75
Prev. Close: 13.75
FBH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Reorganisation

1 Oct 2018 07:00

RNS Number : 4306C
FBD Holdings PLC
01 October 2018
 

 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES NOTES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT

 

This announcement contains a public disclosure of inside information under Regulation (EU) 596/2014. 

 

1 October 2018

 

FBD Holdings plc ("FBD" or "FBD Group")

FBD Insurance plc ("FBD Insurance")

 

Proposed purchase and cancellation of convertible debt and potential issuance of new €50m Tier 2 subordinated notes

 

FBD is pleased to announce that FBD Insurance has entered into an agreement to purchase and cancel the 70,000,000 7% Convertible Notes (the "Existing Notes") currently held by certain affiliates of Fairfax Financial Holdings Limited (collectively "Fairfax") for approximately €86 million in cash, which will be funded through a combination of existing cash resources and a new issue of subordinated notes (the "Transaction").

 

The purchase of the Existing Notes is subject to certain conditions (including any required regulatory approvals). As part of the Transaction, FBD Insurance is proposing to issue €50,000,000 of new Callable Dated Deferrable Subordinated Notes due 2028 (the "New Notes"). FBD has appointed Goodbody Stockbrokers UC as Sole Lead Manager (the "Manager") and the New Notes are expected to be placed with institutional investors.

 

Background to the Transaction

 

In 2015, FBD Insurance issued the Existing Notes to Fairfax, to strengthen FBD's capital position ahead of the implementation of Solvency II and to position it for future growth.

 

The Existing Notes carry a 7 per cent coupon and are convertible into ordinary shares in FBD at a conversion price (subject to adjustment in specified circumstances) of €8.50 per share at any time between 23 September 2018 and 23 September 2025 at the option of the holder. A mandatory conversion would occur if the 30-day volume weighted average price of FBD shares exceeds €8.50 per share for 180 days from 23 September 2018. On conversion, 8,235,294 new FBD shares would be issued to Fairfax.

 

Rationale for the Transaction

 

The consideration for purchase of the Existing Notes represents a discount of approximately 3 per cent to the 6 month volume weighted average price as at 28 September 2018, the last business day prior to this announcement.

 

The Transaction will have a number of benefits for shareholders:

 

§ Existing shareholders will not suffer any dilution;

 

§ It will optimise and simplify FBD's capital structure; and

 

§ It is expected to reduce ongoing interest costs, which over time should provide increased dividend potential for shareholders.

 

 

 

As at 30 June 2018, FBD had net assets of €280.4m and held the Existing Notes as a €53.3m liability and €18.2m in equity. Following completion of the Transaction, on an unaudited pro-forma basis as at 30 June 2018 FBD would have net assets of €247.6m and FBD Insurance's solvency capital ratio will remain in a very healthy position, above its target range of 120% to 140%.

 

 

Commenting on the transaction,

 

Fiona Muldoon, CEO of FBD said:

 

"This transaction is a great result for our loyal shareholders. It avoids any dilution of their existing shareholdings and ensures that FBD continues to maintain a very strong capital position. Fairfax's investment in 2015 was a meaningful endorsement of our business when we needed it and they have been a fantastic partner. We wish them well. The staff, management team and I look forward to continuing to grow FBD as the only indigenous Irish insurer and to expanding our business in both urban and rural Ireland."

 

Liam Herlihy, Chairman of FBD said:

 

"We would like to thank Fairfax for their investment in FBD. We are proud of FBD's 50 year heritage and we look forward to the future with confidence."

 

 Enquiries

Telephone

 

 

 FBD Holdings plc

 

 Paul Murphy

+ 353 01 409 3494

 

 

 

 

 Powerscourt

 

 Jack Hickey

+ 353 83 448 8339

 

About FBD Holdings plc ("FBD")

FBD is one of Ireland's largest property and casualty insurers, looking after the insurance needs of farmers, consumers and business owners.  Established in the 1960s by farmers for farmers, FBD has built on those roots in agriculture to become a leading general insurer serving the needs of its direct agricultural, small business and consumer customers throughout Ireland. It has a network of 34 branches nationwide. 

 

Forward Looking Statements

Some statements in this announcement are forward-looking. They represent expectations for the Group's business, and involve risks and uncertainties. These forward-looking statements are based on current expectations and projections about future events. The FBD Group believes that current expectations and assumptions with respect to these forward-looking statements are reasonable. However, because they involve known and unknown risks, uncertainties and other factors, which are in some cases beyond the FBD Group's control, actual results or performance may differ materially from those expressed or implied by such forward-looking statements.

 

Other Information

 

This Announcement does not constitute an offer of securities and it is not a prospectus or a prospectus "equivalent" document.

 

The distribution of this Announcement and the offering of the securities referred to in this Announcement in certain jurisdictions may be restricted by law. No action has been taken by FBD, FBD Insurance or the Manager that would permit an offering of such securities or possession or distribution of this Announcement or any other offering or publicity material relating to such securities in any jurisdiction where action for that purpose is required. Persons into whose possession this Announcement comes are required by the FBD, FBD Insurance and the Manager to inform themselves about, and to observe, such restrictions.

 

This Announcement is not for publication, distribution or release, directly or indirectly, in or into the United States (including its territories and dependencies, any State of the United States and the District of Columbia). None of the securities referred to in this Announcement have been or will be registered under the US Securities Act of 1933 (as amended) (the "Securities Act"), and may not be offered or sold in the United States or to, or for the account or benefit of, US persons except subject from an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Neither this Announcement nor the information contained herein constitutes or forms part of an offer to sell or the solicitation of an offer to buy securities in the United States. There will be no public offer of any securities in the United States or in any other jurisdiction.

 

In member states of the EEA, this announcement and any offer of securities if made subsequently is directed only at persons who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive ("Qualified Investors"). Any person in the EEA who acquires securities in any offer of securities (an "investor") or to whom any offer of securities is made will be deemed to have represented and agreed that it is a Qualified Investor. Any investor will also be deemed to have represented and agreed that any securities acquired by it in the offer have not been acquired on behalf of persons other than Qualified Investors in Ireland and/or other Member States (where equivalent legislation exists) for whom the investor has authority to make decisions on a wholly discretionary basis, nor have the securities been acquired with a view to their offer or resale to persons other than such Qualified Investors.

 

The price of securities and any income from them may go down as well as up and investors may not get back the full amount invested on disposal of such securities.

 

Neither the content of FBD's website nor any website accessible by hyperlinks on the FBD's website is incorporated in, or forms part of, this Announcement.

 

No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by the Manager or by any of their respective affiliates or agents as to or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CARWGUQUBUPRGQU
Date   Source Headline
22nd Apr 202412:37 pmRNSHolding(s) in Company
22nd Apr 202410:33 amRNSHolding(s) in Company
18th Apr 20249:40 amRNSHolding(s) in Company
17th Apr 20242:40 pmRNSDirector/PDMR Shareholding
16th Apr 20244:49 pmRNSTotal Voting Rights
16th Apr 20243:52 pmRNSDirector/PDMR Shareholding
15th Apr 20243:59 pmRNSDeath of Independent Non-Executive Director
5th Apr 20241:26 pmRNSHolding(s) in Company
27th Mar 20244:20 pmRNSProposed UK Delisting Resolution
27th Mar 20243:46 pmRNSNotice of AGM
26th Mar 20245:39 pmRNSHolding(s) in Company
12th Mar 20245:06 pmRNSHolding(s) in Company
12th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSFinal Results
13th Feb 20244:44 pmRNSTrading Statement
22nd Dec 202310:58 amRNSHolding(s) in Company
21st Dec 20235:00 pmRNSHolding(s) in Company
13th Dec 20233:26 pmRNSDirector/PDMR Shareholding
11th Dec 202312:13 pmRNSFinancial Calendar 2024
12th Sep 20233:43 pmRNSDirector/PDMR Shareholding
1st Sep 20232:00 pmRNSDirectorate Change
17th Aug 20236:26 pmRNSHolding(s) in Company
17th Aug 20236:16 pmRNSHolding(s) in Company
17th Aug 20238:29 amRNSHolding(s) in Company
11th Aug 20237:00 amRNSHalf-year Report
20th Jun 20233:54 pmRNSDirector/PDMR Shareholding
2nd Jun 20233:07 pmRNSDirector/PDMR Shareholding
26th May 20234:51 pmRNSDirector/PDMR Shareholding
11th May 20233:38 pmRNSResult of AGM
11th May 20237:00 amRNSTrading Statement
28th Apr 20232:00 pmRNSDirectorate Change
20th Apr 20234:13 pmRNSHolding(s) in Company
19th Apr 20233:17 pmRNSHolding(s) in Company
18th Apr 202311:58 amRNSHolding(s) in Company
18th Apr 20237:55 amRNSHolding(s) in Company
17th Apr 20235:21 pmRNSHolding(s) in Company
14th Apr 20233:05 pmRNSTotal Voting Rights
13th Apr 20239:01 amRNSHolding(s) in Company
6th Apr 20231:11 pmRNSAdditional Listing
5th Apr 20233:52 pmRNSDirector/PDMR Shareholding
3rd Apr 20234:00 pmRNSNotice of AGM
10th Mar 20237:00 amRNSFinal Results
6th Mar 20231:35 pmRNSHolding(s) in Company
6th Mar 202310:38 amRNSHolding(s) in Company
22nd Feb 20239:49 amRNSHolding(s) in Company
14th Feb 20234:42 pmRNSTrading Update
13th Feb 20235:56 pmRNSHolding(s) in Company
2nd Feb 20233:06 pmRNSDeath of Non-Executive Director
21st Dec 20221:02 pmRNSHolding(s) in Company
19th Dec 20225:19 pmRNSFinancial Calendar 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.